Disease_category,Disease,Protein,Protein_definition,Method,Nb_SNP,OR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,11,0.91 [0.75-1.10],0.306806522952456
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,2,0.83 [0.60-1.14],0.250867026436375
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,LMNB2,Lamin-B2,Inverse variance weighted,9,1.12 [0.94-1.33],0.220832847139894
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,5,1.01 [0.81-1.26],0.924682407700186
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CD99,CD99 antigen,Inverse variance weighted,4,0.84 [0.69-1.03],0.0932290022698293
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CALB1,Calbindin,Inverse variance weighted,11,1.07 [0.92-1.24],0.379132587818578
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,LMOD1,Leiomodin-1,Inverse variance weighted,6,1.00 [0.90-1.12],0.92746113822853
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,MMP3,Stromelysin-1,Inverse variance weighted,35,1.02 [0.96-1.08],0.58357745894196
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.01 [0.75-1.36],0.954911214011503
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,22,1.04 [0.96-1.12],0.328008609429635
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,EDN1,Endothelin-1,Inverse variance weighted,3,0.97 [0.87-1.08],0.562021075347352
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,RSPO1,R-spondin-1,Inverse variance weighted,14,1.00 [0.93-1.08],0.963942073223943
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,1.02 [0.99-1.06],0.208071393755666
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PCDHB15,Protocadherin beta-15,Inverse variance weighted,43,0.99 [0.96-1.02],0.521413384075025
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,1.03 [0.94-1.12],0.573137480762805
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,18,0.97 [0.91-1.04],0.399443204023857
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,HSPB6,Heat shock protein beta-6,Inverse variance weighted,5,0.86 [0.67-1.09],0.209265797910556
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CDH6,Cadherin-6,Inverse variance weighted,34,1.05 [1.01-1.09],0.0231778965943857
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,41,1.02 [0.99-1.05],0.220591318721211
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,0.96 [0.87-1.06],0.401313461368774
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,18,0.97 [0.92-1.04],0.403560612270978
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,30,0.97 [0.93-1.02],0.296718454768127
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,13,1.02 [0.95-1.10],0.528822735992316
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,15,0.99 [0.95-1.02],0.491207631694879
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,23,1.06 [0.99-1.14],0.0934495195914654
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,5,0.93 [0.72-1.21],0.607357351830008
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,ALCAM,CD166 antigen,Inverse variance weighted,11,0.91 [0.82-1.02],0.109420901632145
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,IMMT,MICOS complex subunit MIC60,Inverse variance weighted,2,1.03 [0.86-1.23],0.786296669477686
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,11,0.98 [0.82-1.18],0.866797666283898
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,42,1.02 [0.97-1.07],0.428898968536963
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CCN4,CCN family member 4,Inverse variance weighted,40,0.99 [0.95-1.03],0.654128860414247
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PALM2,Paralemmin-2,Inverse variance weighted,9,1.11 [1.01-1.22],0.025007388409456
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,62,1.02 [0.99-1.06],0.191658142611797
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.04 [0.96-1.14],0.341935502233082
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CDH3,Cadherin-3,Inverse variance weighted,12,1.04 [0.84-1.29],0.723238908188929
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SCG2,Secretogranin-2,Inverse variance weighted,3,0.91 [0.64-1.28],0.58127130578673
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,LGALS1,Galectin-1,Inverse variance weighted,7,0.98 [0.91-1.06],0.603480250529178
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,30,1.01 [0.96-1.06],0.760294493164443
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,19,0.96 [0.90-1.02],0.204097107161682
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PRSS2,Trypsin-2,Inverse variance weighted,22,1.08 [0.99-1.17],0.0776657791406867
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,15,0.93 [0.84-1.03],0.160795322275431
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SPP1,Osteopontin,Inverse variance weighted,19,0.96 [0.86-1.07],0.435025499669505
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,14,1.01 [0.87-1.17],0.935606562608222
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PPL,Periplakin,Inverse variance weighted,2,1.02 [0.75-1.39],0.882981350347162
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,THBD,Thrombomodulin,Inverse variance weighted,16,1.08 [1.01-1.15],0.0334794445449492
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CST3,Cystatin-C,Inverse variance weighted,13,1.09 [1.01-1.16],0.0178724689925015
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,MMP10,Stromelysin-2,Inverse variance weighted,30,0.99 [0.94-1.04],0.587103254468495
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SEMA3F,Semaphorin-3F,Inverse variance weighted,46,1.10 [1.03-1.18],0.0049971721314091
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,18,1.01 [0.95-1.08],0.717426727566966
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,1.04 [0.93-1.16],0.536281947855632
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,6,1.11 [0.93-1.32],0.230807895075282
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,AMBP,Protein AMBP,Inverse variance weighted,5,1.12 [0.96-1.31],0.151707048576538
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,JAM3,Junctional adhesion molecule C,Inverse variance weighted,8,1.03 [0.86-1.23],0.733610694153479
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,MSLN,Mesothelin,Inverse variance weighted,36,1.00 [0.97-1.04],0.920237520342459
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CYTL1,Cytokine-like protein 1,Inverse variance weighted,10,1.00 [0.97-1.04],0.902889488110382
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,6,1.16 [0.96-1.41],0.129168896820054
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,11,1.05 [0.97-1.15],0.250946808232728
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,10,1.05 [0.93-1.19],0.41744483871225
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,1.04 [0.90-1.20],0.638504062588561
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,4,1.05 [0.91-1.21],0.531663988079025
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,5,1.15 [0.87-1.54],0.325843782741343
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1.07 [1.00-1.15],0.064190108415062
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,29,1.01 [0.95-1.08],0.766166794683339
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,19,1.01 [0.96-1.07],0.707120074362043
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,5,0.98 [0.86-1.11],0.774156151663936
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,30,1.01 [0.95-1.08],0.641241632527228
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,NPPC,C-type natriuretic peptide,Inverse variance weighted,5,1.05 [0.72-1.53],0.812523606838807
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SPON1,Spondin-1,Inverse variance weighted,25,0.98 [0.92-1.05],0.606367633739956
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.07 [0.87-1.30],0.52687529925644
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,17,1.05 [0.98-1.12],0.146700504065406
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,35,0.99 [0.94-1.03],0.559524582702694
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,18,1.06 [0.99-1.13],0.0731080616976343
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,RGMB,RGM domain family member B,Inverse variance weighted,10,0.94 [0.85-1.04],0.222003002816231
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,EFNA1,Ephrin-A1,Inverse variance weighted,15,1.11 [1.04-1.18],0.001470233463967
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,0.97 [0.93-1.01],0.191649973340306
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,1.03 [0.91-1.16],0.627043717408636
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,24,0.99 [0.92-1.07],0.767057658295584
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,VWC2,Brorin,Inverse variance weighted,35,1.08 [1.02-1.15],0.0136823707071141
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,23,1.01 [0.96-1.07],0.656968923413733
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,1.15 [0.75-1.77],0.527225010166926
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,0.98 [0.92-1.05],0.620755566331856
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,17,0.99 [0.94-1.06],0.860887798519919
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,UMOD,Uromodulin,Inverse variance weighted,62,1.03 [1.00-1.06],0.0660432647065448
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,0.99 [0.96-1.01],0.346552058137427
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,4,0.99 [0.89-1.11],0.927156304870607
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PSAP,Prosaposin,Inverse variance weighted,13,1.07 [0.99-1.16],0.0734497289590379
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,10,0.99 [0.87-1.13],0.882522563319721
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,1.00 [0.90-1.12],0.960062851930254
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,37,0.99 [0.94-1.04],0.621856015781018
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PGF,Placenta growth factor,Inverse variance weighted,8,0.81 [0.68-0.96],0.0157643580181324
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,IL17C,Interleukin-17C,Inverse variance weighted,8,0.86 [0.73-1.01],0.0635060737330337
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,REG1A,Lithostathine-1-alpha,Inverse variance weighted,26,1.03 [0.98-1.09],0.220678551554014
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,10,1.07 [0.95-1.20],0.284192410668542
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,DPY30,Protein dpy-30 homolog,Inverse variance weighted,2,0.94 [0.42-2.13],0.883088343377229
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CDHR1,Cadherin-related family member 1,Inverse variance weighted,19,1.06 [0.99-1.14],0.107406906730231
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.98 [0.86-1.12],0.776081919336553
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,ITGA11,Integrin alpha-11,Inverse variance weighted,16,1.04 [0.94-1.14],0.47532372200682
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,OGN,Mimecan,Inverse variance weighted,37,0.96 [0.91-1.01],0.122562859739252
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,GDF15,Growth/differentiation factor 15,Inverse variance weighted,14,0.97 [0.86-1.10],0.623697501690104
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,MMP7,Matrilysin,Inverse variance weighted,15,0.99 [0.93-1.05],0.698658476931732
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,40,0.99 [0.94-1.05],0.78231796986063
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,16,0.99 [0.91-1.08],0.869070383158286
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SPON2,Spondin-2,Inverse variance weighted,8,1.10 [1.01-1.20],0.0326062440819561
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,13,1.02 [0.96-1.08],0.53546836759538
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,18,0.86 [0.78-0.95],0.0038899404710926
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,NRP2,Neuropilin-2,Inverse variance weighted,26,0.97 [0.90-1.03],0.324013678472364
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CLMP,CXADR-like membrane protein,Inverse variance weighted,15,1.02 [0.95-1.11],0.54490647709698
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,12,0.91 [0.84-0.98],0.0179117781024495
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CD160,CD160 antigen,Inverse variance weighted,36,1.00 [0.95-1.06],0.956143536606981
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,6,1.01 [0.92-1.11],0.785867993756072
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,29,0.97 [0.93-1.02],0.292295570756144
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.75 [0.60-0.94],0.0117727592404622
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SDC1,Syndecan-1,Inverse variance weighted,14,0.96 [0.87-1.06],0.452590162858017
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,0.88 [0.69-1.12],0.306291896340484
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,4,1.10 [0.93-1.29],0.274531726618655
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,NECTIN4,Nectin-4,Inverse variance weighted,12,1.00 [0.93-1.07],0.989008604981579
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,14,1.09 [0.97-1.24],0.149622605884312
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,RSPO3,R-spondin-3,Inverse variance weighted,11,1.03 [0.93-1.14],0.624417166528555
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,ELN,Elastin,Inverse variance weighted,12,1.01 [0.88-1.15],0.934209549713284
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.47 [0.29-0.75],0.001427895674788
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,38,1.03 [0.98-1.08],0.202624462720847
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,RNASET2,Ribonuclease T2,Inverse variance weighted,25,0.99 [0.95-1.04],0.798918686880775
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,DPT,Dermatopontin,Inverse variance weighted,26,0.95 [0.90-1.02],0.143341339287116
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,49,1.04 [1.00-1.07],0.0428158392954695
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,VIT,Vitrin,Inverse variance weighted,38,1.00 [0.97-1.04],0.919364171418203
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,0.90 [0.62-1.30],0.570053249312668
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CHGB,Secretogranin-1,Inverse variance weighted,33,1.00 [0.96-1.04],0.999516261627613
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.11 [0.94-1.32],0.220436546787049
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,25,1.02 [0.93-1.12],0.658069872930175
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.68 [0.96-2.96],0.0714493056670361
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CHGA,Chromogranin-A,Inverse variance weighted,8,0.97 [0.88-1.06],0.487908784342907
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,RNASE4,Ribonuclease 4,Inverse variance weighted,13,0.95 [0.89-1.01],0.0995881621738477
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,RBP5,Retinol-binding protein 5,Inverse variance weighted,5,0.90 [0.71-1.13],0.367791526751484
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,HNMT,Histamine N-methyltransferase,Inverse variance weighted,32,1.05 [1.01-1.08],0.0113417869675165
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,9,0.89 [0.78-1.02],0.0992762529009326
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,1.00 [0.92-1.10],0.932799808110264
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PTH,Parathyroid hormone,Inverse variance weighted,11,1.13 [1.00-1.27],0.0430088348188766
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CCN5,CCN family member 5,Inverse variance weighted,12,1.01 [0.93-1.10],0.748875820763764
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CA12,Carbonic anhydrase 12,Inverse variance weighted,20,0.95 [0.89-1.02],0.143596753968808
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CCN3,CCN family member 3,Inverse variance weighted,20,0.95 [0.89-1.02],0.153975918873039
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CD59,CD59 glycoprotein,Inverse variance weighted,8,1.01 [0.91-1.11],0.905773154661232
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,20,1.02 [0.97-1.07],0.479308233033551
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,23,1.00 [0.96-1.04],0.91177432272655
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,1.10 [0.92-1.30],0.299599477777486
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,13,1.05 [0.94-1.17],0.392043155959588
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CTSL,Cathepsin L1,Inverse variance weighted,29,1.01 [0.92-1.10],0.893878097434801
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,1.02 [0.82-1.27],0.859958909203733
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,5,1.05 [0.83-1.33],0.668400161960784
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,22,0.99 [0.91-1.07],0.73790430446461
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,11,1.07 [0.93-1.24],0.340697190100377
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,LGALS9,Galectin-9,Inverse variance weighted,39,1.07 [1.02-1.12],0.0037111343768541
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CTSZ,Cathepsin Z,Inverse variance weighted,16,0.99 [0.92-1.08],0.861225785268787
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,VASN,Vasorin,Inverse variance weighted,19,1.00 [0.95-1.04],0.916597876595402
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.97 [0.65-1.45],0.888233942002757
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,13,0.97 [0.83-1.12],0.662427935815799
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.88 [0.62-1.25],0.476115973059372
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PDCD1,Programmed cell death protein 1,Inverse variance weighted,24,1.00 [0.91-1.10],0.992010159768773
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,9,1.10 [0.97-1.26],0.148210074867737
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,22,0.96 [0.89-1.03],0.267492659472336
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,24,0.93 [0.87-0.99],0.0247750448932869
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PENK,Proenkephalin-A,Inverse variance weighted,21,0.98 [0.93-1.04],0.597000712535829
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,15,0.98 [0.91-1.06],0.654293023106109
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,2,1.05 [0.75-1.46],0.789233836857897
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,6,0.91 [0.81-1.03],0.131858916107687
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,VGF,Neurosecretory protein VGF,Inverse variance weighted,2,0.79 [0.43-1.45],0.448564708360539
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,REG1B,Lithostathine-1-beta,Inverse variance weighted,26,1.06 [1.00-1.12],0.0489738599477167
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,35,0.98 [0.92-1.04],0.438615459888901
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,14,0.97 [0.89-1.07],0.59959591433484
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CD27,CD27 antigen,Inverse variance weighted,18,0.96 [0.90-1.03],0.250387063990023
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,3,0.98 [0.83-1.16],0.823732972627781
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,10,1.10 [1.02-1.18],0.00853547716004
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,10,1.06 [0.94-1.19],0.354865342702241
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PRSS8,Prostasin,Inverse variance weighted,19,0.94 [0.84-1.04],0.227056171343255
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,43,1.00 [0.96-1.04],0.978429897898663
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,AGRN,Agrin,Inverse variance weighted,31,0.99 [0.93-1.05],0.719481208408371
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,ANXA10,Annexin A10,Wald ratio,1,0.98 [0.62-1.55],0.935295262414089
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CD300E,CMRF35-like molecule 2,Inverse variance weighted,36,1.03 [0.98-1.08],0.199249250786233
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,IL6,Interleukin-6,Inverse variance weighted,6,0.98 [0.89-1.08],0.692470960993007
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,0.98 [0.89-1.08],0.70319943030445
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,29,1.02 [0.98-1.07],0.313227739520777
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.90 [0.70-1.15],0.380637931415746
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,FOLR1,Folate receptor alpha,Inverse variance weighted,10,1.02 [0.89-1.17],0.748128765693526
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,0.99 [0.87-1.12],0.844054090420218
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SNCG,Gamma-synuclein,Inverse variance weighted,49,0.98 [0.95-1.01],0.265430748792083
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,16,0.98 [0.91-1.06],0.590915200901093
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PALM,Paralemmin-1,Inverse variance weighted,10,0.89 [0.80-1.00],0.0514527405671605
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1.00 [0.93-1.07],0.982435877893036
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,8,0.93 [0.83-1.04],0.209874371350102
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,12,0.96 [0.84-1.09],0.495833657054137
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,9,1.15 [1.02-1.30],0.0194308081042179
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.99 [0.92-1.06],0.76682470090411
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,0.93 [0.74-1.19],0.572856077673129
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,19,1.03 [0.96-1.10],0.450620489405485
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,ITGAV,Integrin alpha-V,Inverse variance weighted,14,1.07 [0.95-1.20],0.276401597716873
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,18,0.98 [0.91-1.05],0.529940413447694
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,15,1.07 [0.95-1.21],0.273394320542868
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,1.04 [0.84-1.28],0.725993717724964
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,31,1.01 [0.92-1.11],0.817623237589727
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1.01 [0.96-1.06],0.659377190508369
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,EFNA4,Ephrin-A4,Inverse variance weighted,5,0.94 [0.79-1.11],0.45653727868722
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PCDH17,Protocadherin-17,Inverse variance weighted,47,1.04 [1.01-1.08],0.0254284519447126
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,26,1.00 [0.95-1.05],0.914710248073523
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,19,0.97 [0.92-1.03],0.339494818132146
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,OCLN,Occludin,Inverse variance weighted,3,0.96 [0.79-1.18],0.71432405337247
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.84 [0.57-1.23],0.373338886514772
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,RTN4R,Reticulon-4 receptor,Inverse variance weighted,26,1.06 [1.00-1.12],0.0348934376543823
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,17,0.96 [0.89-1.03],0.236580495705393
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CD302,CD302 antigen,Inverse variance weighted,17,1.04 [0.94-1.15],0.476848095327853
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TGFA,Protransforming growth factor alpha,Inverse variance weighted,11,0.91 [0.81-1.03],0.151989784483503
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,23,0.99 [0.91-1.08],0.820819142473126
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.17 [0.97-1.41],0.0919287557872537
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,11,1.09 [0.97-1.22],0.159422773423344
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,FGF23,Fibroblast growth factor 23,Inverse variance weighted,17,1.16 [1.02-1.32],0.0195419513085465
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,28,1.00 [0.96-1.04],0.950681376927742
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,76,1.00 [0.98-1.02],0.733167519058939
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,25,1.00 [0.95-1.06],0.939791521328602
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,31,1.04 [0.97-1.11],0.292079146481799
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,0.98 [0.89-1.09],0.705174791385587
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,DTNB,Dystrobrevin beta,Inverse variance weighted,4,0.85 [0.64-1.14],0.282821346276656
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,17,1.00 [0.90-1.11],0.949120634023836
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,EBI3_IL27,Interleukin-27,Inverse variance weighted,37,1.00 [0.95-1.05],0.929634309232565
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,17,0.95 [0.89-1.01],0.117921001480702
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,10,1.01 [0.90-1.13],0.861626587030832
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,GUCA2A,Guanylin,Inverse variance weighted,16,0.98 [0.90-1.07],0.725269731075325
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.00 [0.96-1.04],0.932379446462953
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,NUCB2,Nucleobindin-2,Inverse variance weighted,28,0.95 [0.88-1.02],0.124521058971168
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,18,0.91 [0.79-1.04],0.154627681213089
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,24,1.02 [0.96-1.08],0.551290229957458
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,1.00 [0.96-1.04],0.899876466612572
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,5,1.08 [0.90-1.30],0.411726699873304
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,FABP6,Gastrotropin,Inverse variance weighted,5,0.91 [0.79-1.05],0.214998313276684
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,THBS2,Thrombospondin-2,Inverse variance weighted,33,1.02 [0.97-1.06],0.439049132066863
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,39,1.01 [0.97-1.06],0.643910519980899
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SHISA5,Protein shisa-5,Inverse variance weighted,16,0.91 [0.78-1.05],0.183078744712473
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CD55,Complement decay-accelerating factor,Inverse variance weighted,27,0.94 [0.89-1.00],0.0450590096972331
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,IL19,Interleukin-19,Inverse variance weighted,21,1.01 [0.96-1.06],0.665593777548796
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,FSTL3,Follistatin-related protein 3,Inverse variance weighted,7,0.99 [0.86-1.13],0.852879437581698
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,3,1.06 [0.86-1.31],0.609604739607864
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.01 [0.75-1.36],0.952360379441308
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CDH15,Cadherin-15,Inverse variance weighted,22,0.96 [0.91-1.01],0.149438381978286
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,DLL1,Delta-like protein 1,Inverse variance weighted,13,0.98 [0.88-1.09],0.720694313959607
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,42,1.03 [0.98-1.07],0.27781061313911
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.08 [0.90-1.30],0.387271325096847
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,ACTN2,Alpha-actinin-2,Inverse variance weighted,4,0.92 [0.73-1.16],0.503055085662604
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,WNT9A,Protein Wnt-9a,Inverse variance weighted,7,1.01 [0.89-1.16],0.834505152222608
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CDH1,Cadherin-1,Inverse variance weighted,17,0.98 [0.91-1.06],0.623835825536765
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,MB,Myoglobin,Inverse variance weighted,10,1.01 [0.82-1.26],0.906098253294523
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,1.06 [0.93-1.21],0.396406544157418
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,22,1.04 [0.99-1.09],0.116486834037056
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CFC1,Cryptic protein,Inverse variance weighted,11,1.07 [0.92-1.23],0.395166334470642
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.05 [0.94-1.18],0.370721915011692
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,IL15,Interleukin-15,Inverse variance weighted,35,0.99 [0.92-1.06],0.80014036028547
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,5,0.85 [0.63-1.16],0.313033886108702
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,23,1.03 [0.99-1.07],0.14903836366516
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,14,1.07 [0.96-1.19],0.195514117068209
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,3,1.00 [0.80-1.25],0.994710933575168
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,20,1.04 [0.97-1.11],0.329855221971406
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,ANG,Angiogenin,Inverse variance weighted,25,1.03 [0.98-1.08],0.292248914892087
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,RTBDN,Retbindin,Inverse variance weighted,5,0.92 [0.77-1.09],0.341443074158382
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,BGLAP,Osteocalcin,Inverse variance weighted,10,0.96 [0.82-1.11],0.552708709706553
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,24,1.02 [0.95-1.10],0.512089286208471
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,13,0.95 [0.86-1.06],0.369038142965988
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CALB2,Calretinin,Wald ratio,1,1.32 [0.90-1.92],0.151863958781597
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PGA4,Pepsin A-4,Inverse variance weighted,9,1.16 [1.00-1.36],0.0572801876301267
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,15,0.99 [0.92-1.08],0.860045747743069
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,1.01 [0.94-1.08],0.868816652904485
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,15,0.98 [0.92-1.04],0.474100938325157
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CD276,CD276 antigen,Inverse variance weighted,47,1.02 [0.99-1.06],0.196006234322294
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,17,1.05 [0.96-1.15],0.266636719771426
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,NECTIN2,Nectin-2,Inverse variance weighted,8,0.97 [0.91-1.03],0.336919947932655
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,1.02 [0.96-1.07],0.545053364346006
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,13,0.95 [0.80-1.13],0.531292873531691
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,19,1.03 [0.94-1.14],0.53347782502646
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,REN,Renin,Inverse variance weighted,12,0.94 [0.88-1.02],0.132848157176125
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CD83,CD83 antigen,Inverse variance weighted,19,1.00 [0.92-1.09],0.945016999886806
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,1.00 [0.92-1.10],0.92135791116465
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.09 [0.94-1.27],0.238543291065005
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,19,0.99 [0.91-1.07],0.749828034603686
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,0.99 [0.95-1.03],0.599975474547025
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,16,1.01 [0.95-1.08],0.689549349088966
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,31,1.00 [0.96-1.05],0.855745983174709
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,10,0.88 [0.76-1.02],0.0859980482726861
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,32,0.98 [0.96-1.01],0.222503849391686
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.94 [0.77-1.14],0.530435000130365
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,INHBB,Inhibin beta B chain,Inverse variance weighted,16,0.90 [0.79-1.02],0.0892514551059148
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,31,1.02 [0.98-1.05],0.354077868443117
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,ZBTB17,Zinc finger and BTB domain-containing protein 17,Inverse variance weighted,2,1.09 [0.83-1.43],0.520202378028673
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,22,1.00 [0.94-1.05],0.884782685185149
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CA9,Carbonic anhydrase 9,Inverse variance weighted,11,1.03 [0.92-1.15],0.666939101964968
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CFD,Complement factor D,Inverse variance weighted,12,1.01 [0.93-1.09],0.887626337447773
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,40,0.97 [0.91-1.02],0.253415726454598
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,8,1.05 [0.89-1.24],0.560500082728045
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,FBLN2,Fibulin-2,Inverse variance weighted,17,1.00 [0.95-1.06],0.949953619889955
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TMSB10,Thymosin beta-10,Wald ratio,1,1.17 [0.79-1.75],0.42854188159618
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,Inverse variance weighted,2,0.96 [0.52-1.75],0.884977159359677
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,MMP13,Collagenase 3,Inverse variance weighted,2,0.84 [0.56-1.26],0.390695581684808
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.04 [0.95-1.14],0.384590334723433
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,10,0.93 [0.84-1.04],0.207552033855685
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CD46,Membrane cofactor protein,Inverse variance weighted,3,0.84 [0.70-1.02],0.0859134198853912
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,KLK11,Kallikrein-11,Inverse variance weighted,19,0.94 [0.90-0.98],0.0080231515881583
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,20,1.00 [0.97-1.04],0.980929723982265
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,21,0.96 [0.84-1.10],0.547531519491367
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PCDH12,Protocadherin-12,Inverse variance weighted,17,1.06 [0.98-1.14],0.152815486517802
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,17,1.01 [0.94-1.08],0.805865510300145
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,24,0.97 [0.90-1.04],0.333459232532651
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,BSG,Basigin,Inverse variance weighted,8,1.13 [0.97-1.31],0.116342883226649
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,54,1.01 [0.97-1.05],0.609256684601124
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,35,1.01 [0.98-1.05],0.393576834416107
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PLIN3,Perilipin-3,Wald ratio,1,0.98 [0.71-1.36],0.921885979994142
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,MSMB,Beta-microseminoprotein,Inverse variance weighted,92,1.01 [0.99-1.03],0.302880490849138
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,12,1.06 [0.86-1.30],0.606740634530234
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,STC2,Stanniocalcin-2,Inverse variance weighted,12,1.11 [0.98-1.27],0.0937737269410411
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.12 [0.92-1.36],0.256312457205344
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,2,0.96 [0.76-1.22],0.750429764450433
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,15,1.05 [0.98-1.13],0.18531481062138
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,8,0.94 [0.88-1.01],0.0961567358035832
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,28,1.02 [0.97-1.06],0.469735378403755
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,26,0.97 [0.93-1.02],0.239426681306913
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,11,1.03 [0.96-1.11],0.374695447687412
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,DSC2,Desmocollin-2,Inverse variance weighted,16,0.96 [0.88-1.05],0.376158481389272
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CSTB,Cystatin-B,Inverse variance weighted,25,0.99 [0.94-1.04],0.652884474781501
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,KLK4,Kallikrein-4,Inverse variance weighted,20,1.02 [0.97-1.08],0.444147164156753
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CD93,Complement component C1q receptor,Inverse variance weighted,2,0.84 [0.62-1.13],0.257758360644078
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,APOA2,Apolipoprotein A-II,Inverse variance weighted,16,1.06 [0.94-1.20],0.333447750233334
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,34,1.02 [0.98-1.06],0.274379203318849
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,RETN,Resistin,Inverse variance weighted,28,0.98 [0.93-1.02],0.318273181576756
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,3,0.88 [0.64-1.20],0.406276779734254
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,8,1.05 [0.92-1.19],0.481638117054887
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CD7,T-cell antigen CD7,Inverse variance weighted,12,0.98 [0.93-1.03],0.374699689409925
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,8,0.95 [0.84-1.08],0.452847838138074
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CXCL13,C-X-C motif chemokine 13,Inverse variance weighted,2,1.01 [0.73-1.40],0.942748768727004
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,FAM3C,Protein FAM3C,Inverse variance weighted,5,1.09 [0.85-1.39],0.487871566175751
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,61,1.00 [0.98-1.03],0.772952764677354
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,41,0.96 [0.90-1.01],0.12793751331662
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,0.95 [0.71-1.27],0.724882166863393
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.01 [0.97-1.05],0.705286824465253
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,24,0.95 [0.89-1.01],0.108272948758274
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CX3CL1,Fractalkine,Inverse variance weighted,23,1.04 [0.97-1.12],0.276740571130724
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,22,1.01 [0.97-1.05],0.630941960224276
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PI3,Elafin,Inverse variance weighted,20,1.00 [0.94-1.07],0.974552234420097
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CALCA,Calcitonin,Inverse variance weighted,17,1.07 [0.92-1.25],0.394472538491232
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,1.04 [0.97-1.12],0.283747126290387
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,59,0.99 [0.95-1.03],0.649840095602919
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,24,1.07 [1.00-1.15],0.0383218193922911
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,5,0.99 [0.81-1.21],0.913297578654082
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,0.97 [0.92-1.02],0.188347030647318
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,27,1.01 [0.95-1.08],0.757599135746599
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,LAYN,Layilin,Inverse variance weighted,23,0.98 [0.92-1.04],0.483171195717359
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,11,1.07 [0.96-1.18],0.229279420443912
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,DRAXIN,Draxin,Inverse variance weighted,38,1.05 [1.00-1.10],0.0502701039593138
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.90 [0.80-1.01],0.0828070548574248
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,LGALS4,Galectin-4,Inverse variance weighted,19,1.00 [0.93-1.08],0.947014419142817
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SEPTIN8,Septin-8,Inverse variance weighted,6,0.88 [0.74-1.05],0.16911133960763
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,MDK,Midkine,Inverse variance weighted,19,0.93 [0.83-1.04],0.223114653154423
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,MEPE,Matrix extracellular phosphoglycoprotein,Inverse variance weighted,27,0.90 [0.82-0.98],0.0162462064079564
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,GM2A,Ganglioside GM2 activator,Inverse variance weighted,26,0.99 [0.96-1.03],0.618881528130825
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,COLEC12,Collectin-12,Inverse variance weighted,13,0.99 [0.90-1.09],0.88291202966084
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,0.91 [0.62-1.33],0.629687544139297
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,1.04 [0.92-1.18],0.546756182649975
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,13,0.99 [0.95-1.04],0.74610383354832
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,22,0.97 [0.90-1.05],0.487232118260837
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,0.96 [0.88-1.03],0.242357411411368
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CTSV,Cathepsin L2,Inverse variance weighted,34,0.98 [0.93-1.04],0.573332531523103
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.02 [0.95-1.09],0.622807521746146
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,6,1.01 [0.91-1.11],0.878998016620272
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,DKK4,Dickkopf-related protein 4,Inverse variance weighted,18,1.13 [1.00-1.26],0.0428774953212274
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,8,0.98 [0.85-1.13],0.784702058444045
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,ULBP2,UL16-binding protein 2,Inverse variance weighted,37,0.99 [0.96-1.02],0.434581138668147
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,XG,Glycoprotein Xg,Inverse variance weighted,2,0.84 [0.45-1.54],0.56282922342614
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,PRL,Prolactin,Inverse variance weighted,7,1.21 [0.91-1.61],0.188728394055502
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CKB,Creatine kinase B-type,Inverse variance weighted,11,0.98 [0.85-1.13],0.768715737756164
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,29,1.04 [1.00-1.09],0.0553065337588394
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TFF2,Trefoil factor 2,Inverse variance weighted,16,1.09 [0.96-1.22],0.170180540212162
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,28,0.99 [0.95-1.04],0.785076212233771
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,13,1.07 [0.96-1.18],0.229530986989282
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,RNASE6,Ribonuclease K6,Inverse variance weighted,20,0.99 [0.95-1.05],0.838883586648982
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,ADM,Pro-adrenomedullin,Inverse variance weighted,4,1.08 [0.96-1.21],0.181978996765479
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,21,1.00 [0.92-1.09],0.983191250508018
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,38,0.97 [0.93-1.00],0.0501273651471454
"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,AREG,Amphiregulin,Inverse variance weighted,7,1.03 [0.91-1.17],0.596433769813906
